What Ferritin Patterns Actually Tell Us About Fatigue, ADHD, and PMDD
If your iron came back normal, you may have been told there is nothing to investigate. But what your lab report says is “normal” and what is actually optimal for your brain, your hormones, and your energy are often two different things.
Ferritin is one of the most misread markers in standard lab work. This post will explain what ferritin actually measures, why the reference ranges on your report may be too low to catch a real problem, and what the research tells us about ferritin’s connection to fatigue, ADHD, and PMDD.
What Is Ferritin and Why Does It Matter?
Ferritin is a protein that stores iron inside your cells. When you measure serum ferritin, you are getting a snapshot of how much iron your body has in reserve. It is the most sensitive early marker of iron depletion, often falling well before hemoglobin or other markers show any change (Leung et al., 2024).
Iron is not just involved in making red blood cells. It plays a direct role in:
Dopamine synthesis and dopamine receptor density in the brain
Serotonin and norepinephrine production
Myelin formation in the central nervous system
Mitochondrial energy production
Thyroid hormone conversion
This means that iron status affects your brain chemistry, your mood, your focus, and your fatigue levels, even before you are technically anemic (Leung et al., 2024).
The Problem with “Normal” Ferritin Ranges
Standard lab reference ranges for ferritin in adult women typically start as low as 10 to 13 µg/L. This number has been widely criticized in the research literature as far too low to reflect actual iron adequacy, particularly for women of reproductive age.
A 2024 systematic review published in The Lancet Haematology examined 61 studies that established ferritin reference intervals in healthy adults and found that the median lower limit of normal for females was only 8 µg/L. The authors concluded that these reference intervals are at high risk of bias because the study populations used to establish them were not adequately screened to exclude women who were already iron deficient, particularly menstruating women who are at the highest risk of iron depletion (Truong et al., 2024).
In other words, the “normal” range may have been built from data that included iron-deficient women all along.
The same review noted that a ferritin below 30 µg/L has 92% sensitivity and 98% specificity for true iron deficiency that correlates with absent bone marrow iron stores. Yet the majority of commercial lab assays continue to report a lower limit of normal well below that threshold (Truong et al., 2024).
A 2025 review published in Diagnostics examined the global debate around ferritin cutoffs and concluded that the World Health Organization’s threshold of less than 15 ng/mL may miss up to 50% of individuals who are truly iron deficient, particularly premenopausal women. A systematic review of 55 studies found that a ferritin threshold of less than 45 ng/mL had a sensitivity of 85% and specificity of 92% for iron deficiency, compared to only 59% sensitivity for the WHO cutoff of less than 15 ng/mL (Cancado et al., 2025).
That same review cited a pooled analysis of 1,058 healthy women that found iron absorption increased below a physiological threshold of approximately 51.1 ng/mL, above which absorption remained stable. This suggests that below roughly 50 ng/mL, the body recognizes a state of iron insufficiency even when standard labs would call the number normal (Cancado et al., 2025).
Ferritin Is Also an Inflammatory Marker
There is another layer of complexity that makes ferritin harder to interpret than most providers realize. Ferritin is an acute phase reactant. This means that in the presence of inflammation, infection, chronic disease, or even metabolic stress, ferritin can appear elevated or normal even when iron stores are actually depleted (DePalma et al., 2021).
Conditions that can artificially elevate ferritin include chronic inflammation, thyroid dysfunction, liver disease, obesity, insulin resistance, and autoimmune conditions (DePalma et al., 2021).
This is clinically significant for the populations seen in functional medicine practice. A woman with Hashimoto’s thyroiditis, chronic low-grade inflammation, and fatigue could have a ferritin of 40 ng/mL that looks borderline acceptable on a standard report, but the inflammatory context may mean her true iron availability is lower than that number suggests.
When inflammation is present, looking at the full iron panel, including serum iron, TIBC, transferrin saturation, and ideally a CRP, gives a more complete picture than ferritin alone.
Low Ferritin and Fatigue in Non-Anemic Women
One of the most clinically meaningful bodies of evidence in this space involves fatigue in women who have low ferritin but no anemia. These women are told their iron is fine because their hemoglobin is normal. But the research tells a different story.
In a randomized controlled trial published in the BMJ, non-anemic women with unexplained fatigue were assigned to receive oral iron or placebo. Fatigue significantly improved in the iron group compared to placebo. The benefit was observed specifically in women with ferritin concentrations at or below 50 µg/L (Verdon et al., 2003).
A second randomized controlled trial published in the Canadian Medical Association Journal enrolled 198 non-anemic menstruating women with ferritin below 50 µg/L and assigned them to iron supplementation or placebo. The iron group experienced significantly greater improvement in fatigue scores at the end of the study period, though quality-of-life and mood measures did not change significantly (Vaucher et al., 2012).
A third trial published in Blood examined the use of intravenous iron in non-anemic premenopausal women with low ferritin. While overall results across the group were modest at six weeks, the subgroup with ferritin at or below 15 ng/mL demonstrated a clearer benefit from iron treatment (Krayenbuehl et al., 2011).
A 2020 systematic review that analyzed 15 randomized controlled trials on iron supplementation in women of reproductive age found that five of seven studies examining fatigue as an outcome reported statistically significant improvement. The authors noted that the evidence was heterogeneous in methodology, but the directional signal across trials was consistent: non-anemic women with low ferritin are likely to experience fatigue improvement with iron (Avery et al., 2020).
Taken together, this evidence supports a functional ferritin threshold closer to 50 µg/L as clinically meaningful for women with fatigue, even in the absence of anemia.
Ferritin and ADHD:
What the Research Shows in Children
Iron’s relationship with ADHD is one of the clearest examples in the research of how a nutrient affects brain function at a mechanistic level.
Iron is a required cofactor in the synthesis of dopamine. It is involved in the function of dopamine receptors and in the activity of the enzyme tyrosine hydroxylase, which is the rate-limiting step in dopamine production. Brain iron levels influence dopamine-dependent functions including attention, impulse control, and executive function (Leung et al., 2024).
In a controlled group comparison study published in the Archives of Pediatric and Adolescent Medicine, Konofal and colleagues measured serum ferritin in 53 children with ADHD and 27 age- and sex-matched controls. Mean ferritin was 23 ng/mL in the ADHD group compared to 44 ng/mL in controls. Ferritin below 30 ng/mL was found in 84% of children with ADHD compared to 18% of controls. Low ferritin was inversely correlated with ADHD symptom severity on the Conners Parent Rating Scale. Notably, hemoglobin and hematocrit were normal in both groups, meaning these children would not have been identified as iron deficient by standard anemia screening (Konofal et al., 2004).
The authors hypothesized that low iron stores may contribute to impaired dopaminergic activity in children with ADHD, and that iron status may explain as much as 30% of ADHD severity in their sample (Konofal et al., 2004).
A subsequent large population-based study cited in the updated iron deficiency anemia review found that children with iron deficiency anemia had an increased odds of an ADHD diagnosis (OR 1.67; 95% CI 1.29 to 2.17) compared to children without iron deficiency anemia, in a cohort of nearly 15,000 children (Leung et al., 2024).
These findings do not establish iron deficiency as a cause of ADHD. ADHD is a highly heritable, polygenic condition with multiple contributing factors. However, iron status is one of the most biologically plausible and modifiable factors that may be amplifying symptoms in individuals who are predisposed.
Ferritin and PMDD: A More Cautious Picture
The research on ferritin and PMDD specifically is thinner and less settled than the fatigue and ADHD literature. There is no strong, direct evidence establishing low ferritin as a driver of PMDD.
What the literature does suggest is that low iron status may worsen overlapping symptoms. A small study of marginally iron-deficient young women found more nonspecific psychological symptoms during the luteal phase compared to iron-replete controls. A Mendelian randomization study found that women with a genetic predisposition to higher iron stores reported fewer certain premenstrual symptoms including headache, confusion, and nausea. One study specifically examining low iron status genotypes and premenstrual symptoms found no significant associations with PMDD diagnosis itself (cited in Cancado et al., 2025).
The working clinical picture is this: low ferritin does not cause PMDD, but it may amplify the fatigue, headache, irritability, and cognitive symptoms that overlap with the PMDD symptom profile, particularly in the luteal phase when these symptoms are already most pronounced.
For women managing PMDD, iron status is worth assessing as part of a broader picture, not because it is the primary driver, but because it is one of the more straightforward factors to identify and address.
What a Functional Ferritin Workup Actually Looks At
A standard ferritin result does not tell the full story on its own. Here is what a more complete iron panel looks at and why each marker matters:
Serum ferritin: iron storage. The most sensitive early marker of depletion, but can be artificially elevated by inflammation.
Serum iron: the amount of iron currently circulating. Can fluctuate throughout the day and with diet.
Total iron-binding capacity (TIBC): reflects how much transferrin is available to carry iron. TIBC rises when iron stores are low, as the body upregulates its transport capacity.
Transferrin saturation: serum iron divided by TIBC. Below 16% is generally consistent with iron deficiency regardless of ferritin.
CRP or inflammatory markers: essential context when ferritin is in the indeterminate range, because inflammation can mask true iron status.
A ferritin that looks acceptable in isolation may paint a very different picture when seen alongside a low transferrin saturation, a rising TIBC, and an elevated CRP. This is the kind of pattern reading that standard blood work interpretations often miss.
What This Means Clinically
The research supports several things that standard lab interpretation often does not account for:
A ferritin below 30 µg/L is associated with true iron deficiency at the bone marrow level, regardless of what the reference range on your lab report says (Truong et al., 2024).
Fatigue in non-anemic menstruating women with ferritin below 50 µg/L is associated with improved outcomes from iron supplementation across multiple randomized trials (Verdon et al., 2003; Vaucher et al., 2012; Krayenbuehl et al., 2011; Avery et al., 2020).
Low ferritin is associated with ADHD in children and inversely correlated with symptom severity in an observational study (Konofal et al., 2004).
Standard reference ranges may have been established from populations that included iron-deficient women, making the lower limit of normal structurally too low (Truong et al., 2024).
Ferritin should always be interpreted in clinical context, not as a single number in isolation.
The recommendation in functional practice is not to supplement based on a number alone. It is to understand the pattern, assess contributing factors, and support the body with what it actually needs.
If You Have Labs Sitting Somewhere with a “Normal” Ferritin
This is exactly the kind of pattern I look at in a Read Between the Labs session. If you have existing blood work and you want to understand what the numbers actually mean in context, an RBTL session gives you a 30-minute telehealth review with a written summary within 72 hours.
It is a $99 starting point. No new labs required.
If you would like to talk through whether a deeper functional lab package is the right fit, you can book a free discovery call.
References
Avery, H., Jackson, P., & Haskell-Ramsay, C. (2020). The effect of iron supplementation on cognition, subjective mood, well-being and fatigue in women of reproductive age: A systematic review. Proceedings of the Nutrition Society, 79(OCE2), E330. https://doi.org/10.1017/S0029665120002785
Cancado, R. D., Leite, L. A. C., & Muñoz, M. (2025). Defining global thresholds for serum ferritin: A challenging mission in establishing the iron deficiency diagnosis in this era of striving for health equity. Diagnostics, 15(3), 289. https://doi.org/10.3390/diagnostics15030289
DePalma, R. G., Hayes, V. W., & O’Leary, T. J. (2021). Optimal serum ferritin level range: Iron status measure and inflammatory biomarker. [Preprint]. https://doi.org/10.1093/mfab030
Konofal, E., Lecendreux, M., Arnulf, I., & Mouren, M.-C. (2004). Iron deficiency in children with attention-deficit/hyperactivity disorder. Archives of Pediatric and Adolescent Medicine, 158(12), 1113–1115. https://doi.org/10.1001/archpedi.158.12.1113
Krayenbuehl, P.-A., Battegay, E., Breymann, C., Furrer, J., & Schulthess, G. (2011). Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood, 118(12), 3222–3227. https://doi.org/10.1182/blood-2011-04-346304
Leung, A. K. C., Lam, J. M., Wong, A. H. C., Hon, K. L., & Li, X. (2024). Iron deficiency anemia: An updated review. Current Pediatric Reviews, 20(3), 339–356. https://doi.org/10.2174/1573396320666230727102042
Truong, J., Naveed, K., Beriault, D., Lightfoot, D., Fralick, M., & Sholzberg, M. (2024). The origin of ferritin reference intervals: A systematic review. The Lancet Haematology, 11(7), e530–e539. https://doi.org/10.1016/S2352-3026(24)00143-0
Vaucher, P., Druais, P.-L., Waldvogel, S., & Favrat, B. (2012). Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: A randomized controlled trial. Canadian Medical Association Journal, 184(11), 1247–1254. https://doi.org/10.1503/cmaj.110950
Verdon, F., Burnand, B., Stubi, C. F., Bonard, C., Graff, M., Michaud, A., & Burnand, B. (2003). Iron supplementation for unexplained fatigue in non-anaemic women: Double blind randomised placebo controlled trial. BMJ, 326(7399), 1124. https://doi.org/10.1136/bmj.326.7399.1124
